Vistagen therapeutics inc

Major-Pharmaceuticals

VTGN


343 Allerton Avenue
South San Francisco , CA 94080

Executive/
Director

Price

  • Last Close
  • $ 0.1
    $ -0.03 -25.37 %
    Jun 6, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 16,328,703
  • Market Cap Full
  • $ 2.7M
  • Shares Outstanding
  • 27M
    Nov 9, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - -47.5% -16.2% -14.7% -5% 9.8% -36.4% 21.4% - -
Q2 -5.1% -4.6% 45.7% -43.6% 4% 47.9% -29% -20% - -
Q3 8.5% -14.4% 2.8% 48% 8% -12.9% -83% - - -
Q4 -11.8% -32.7% 1.4% -40.8% 177.1% -29% -31.3% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%-70%35%-56%195%1%-95%-3%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.32 -0.06 -0.16 -0.07 -0.3 -0.09 -1.60
Q2 - 0.28 -0.2 -0.15 -0.07 -0.04 -0.1 -0.94
Q3 0.42 0.53 -0.3 -0.13 -0.05 -0.07 -0.08 -0.66
Q4 0.34 0.24 -0.24 -0.15 -0.07 -0.05 -1.50 -
A 0.8 1.4 -0.8 -0.6 -0.3 -0.5 -1.77 -3.2

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 31.1 48 141.7 206.5 219.3
Jun - 42.6 55.8 191.4 206.6 7.9
Sep 25.8 42.6 74 192.9 206.8 9.4
Dec 31.1 43.2 74 199.7 206.8 27

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -10.3
Equity multiplier - - - - -